PNS48 Do US Commercial Health Plans Cite ICER Reports in Their Specialty Drug Coverage Policies? an Empirical Analysis

2021 ◽  
Vol 24 ◽  
pp. S181
Author(s):  
D. Enright ◽  
A. Panzer ◽  
J. Chambers
Keyword(s):  
Empirical Analysis ◽  
Drug Coverage ◽  
Health Plans

scholarly journals RE1 DO HEALTH PLANS CITE REAL-WORLD EVIDENCE IN THEIR SPECIALTY DRUG COVERAGE POLICIES? AN EMPIRICAL ANALYSIS

2020 ◽  
Vol 23 ◽  
pp. S383
Author(s):  
A. Panzer ◽  
N. Margaretos ◽  
R. Lai ◽  
D.E. Enright ◽  
J. Chambers
Keyword(s):  
Empirical Analysis ◽  
Real World ◽  
Drug Coverage ◽  
Health Plans ◽  
Real World Evidence

Specialty Drug Coverage Varies Across Commercial Health Plans In The US

2018 ◽  
Vol 37 (7) ◽  
pp. 1041-1047 ◽  
Author(s):  
James D. Chambers ◽  
David D. Kim ◽  
Elle F. Pope ◽  
Jennifer S. Graff ◽  
Colby L. Wilkinson ◽  
...  
Keyword(s):  
Drug Coverage ◽  
Health Plans ◽  
The Us

scholarly journals Variation in health plan specialty drug coverage: an empirical analysis

2019 ◽  
Vol 8 (sup1) ◽  
pp. 13-13
Author(s):  
Nikoletta M. Margaretos ◽  
Rachel C. Lai ◽  
Ari D. Panzer ◽  
James D. Chambers
Keyword(s):  
Empirical Analysis ◽  
Health Plan ◽  
Drug Coverage

Switching Health Plans to Obtain Drug Coverage

JAMA ◽  
2000 ◽  
Vol 283 (16) ◽  
pp. 2161 ◽  
Author(s):  
Joseph P. Newhouse
Keyword(s):  
Drug Coverage ◽  
Health Plans

What types of real‐world evidence studies do U.S. commercial health plans cite in their specialty drug coverage decisions?

2020 ◽  
Vol 29 (10) ◽  
pp. 1307-1311
Author(s):  
Ari D. Panzer ◽  
Nikoletta M. Margaretos ◽  
Rachel C. Lai ◽  
Daniel E. Enright ◽  
James D. Chambers
Keyword(s):  
Real World ◽  
Drug Coverage ◽  
Health Plans ◽  
Real World Evidence

scholarly journals RO3 DO HEALTH PLANS COVER ORPHAN AND NON-ORPHAN DRUGS DIFFERENTLY? AN EMPIRICAL ANALYSIS

2019 ◽  
Vol 22 ◽  
pp. S388-S389
Author(s):  
N. Margaretos ◽  
A. Panzer ◽  
P.J. Neumann ◽  
J. Chambers
Keyword(s):  
Empirical Analysis ◽  
Orphan Drugs ◽  
Health Plans

PNS52 Examining US Commercial Health Plans' Use of Step Therapy Protocols for Specialty Drugs: An Empirical Analysis

2021 ◽  
Vol 24 ◽  
pp. S182
Author(s):  
K. Lenahan ◽  
R.M. Gertler ◽  
D. Nichols ◽  
J.D. Chambers
Keyword(s):  
Empirical Analysis ◽  
Health Plans ◽  
Step Therapy
Sign in / Sign up

Export Citation Format

Share Document